$0.1000
At close: May 14, 3:45 PM EDT
Comments
Loading...
Medigene Analyst Ratings and Price Targets | OTC:MDGEF | Benzinga
Medigene Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Medigene Corp from these most-recent analyst ratings.
Analyst Ratings for Medigene
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Medigene (MDGEF) stock?
There is no price target for Medigene
What is the most recent analyst rating for Medigene (MDGEF)?
There is no analyst for Medigene
When was the last upgrade for Medigene (MDGEF)?
There is no last upgrade for Medigene
When was the last downgrade for Medigene (MDGEF)?
There is no last downgrade for Medigene.
When is the next analyst rating going to be posted or updated for Medigene (MDGEF)?
There is no next analyst rating for Medigene.
Is the Analyst Rating Medigene (MDGEF) correct?
There is no next analyst rating for Medigene.
Browse analyst ratings and price targets on all stocks.
